Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk

Matthews, Philippa C; Ocama, Ponsiano; Wang, Su; El-Sayed, Manal; Turkova, Anna; Ford, Deborah; Torimiro, Judith; Ferreira, Ana Cristina Garcia; Miranda, Angélica Espinosa; De La Hoz Restrepo, Fernando Pio; Seremba, Emmanuel; Mbu, Robinson; Pan, Calvin Q; Razavi, Homie; Dusheiko, Geoffrey; Spearman, C Wendy; Hamid, Saeed

doi:10.25418/crick.24297784.v1

1-s2.0-S2589555923002069-main (1).pdf (369.74 kB)

Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk

journal contribution

posted on 2023-10-12, 09:42 authored by Philippa C Matthews, Ponsiano Ocama, Su Wang, Manal El-Sayed, Anna Turkova, Deborah Ford, Judith Torimiro, Ana Cristina Garcia Ferreira, Angélica Espinosa Miranda, Fernando Pio De La Hoz Restrepo, Emmanuel Seremba, Robinson Mbu, Calvin Q Pan, Homie Razavi, Geoffrey Dusheiko, C Wendy Spearman, Saeed Hamid

No description supplied

Funding

Crick (Grant ID: CC2223, Grant title: Matthews CC2223)

History

Publisher DOI

https://doi.org/10.1016/j.jhepr.2023.100875

Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk

Funding

Crick (Grant ID: CC2223, Grant title: Matthews CC2223)

History

Publisher DOI

Usage metrics

Categories

Keywords

Licence

Exports